Switch to:
Also traded in: Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.40
ANTM's Cash-to-Debt is ranked lower than
76% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.38 vs. ANTM: 0.40 )
Ranked among companies with meaningful Cash-to-Debt only.
ANTM' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.09  Med: 0.25 Max: N/A
Current: 0.4
Equity-to-Asset 0.38
ANTM's Equity-to-Asset is ranked higher than
60% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.34 vs. ANTM: 0.38 )
Ranked among companies with meaningful Equity-to-Asset only.
ANTM' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.33  Med: 0.44 Max: 0.51
Current: 0.38
0.33
0.51
Interest Coverage 6.17
ANTM's Interest Coverage is ranked lower than
78% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.62 vs. ANTM: 6.17 )
Ranked among companies with meaningful Interest Coverage only.
ANTM' s Interest Coverage Range Over the Past 10 Years
Min: 6.3  Med: 7.41 Max: 16.55
Current: 6.17
6.3
16.55
Beneish M-Score: -2.45
WACC vs ROIC
5.66%
15.67%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating Margin % 5.46
ANTM's Operating Margin % is ranked higher than
56% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.19 vs. ANTM: 5.46 )
Ranked among companies with meaningful Operating Margin % only.
ANTM' s Operating Margin % Range Over the Past 10 Years
Min: 5.1  Med: 6.09 Max: 11.38
Current: 5.46
5.1
11.38
Net Margin % 3.19
ANTM's Net Margin % is ranked higher than
52% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.19 vs. ANTM: 3.19 )
Ranked among companies with meaningful Net Margin % only.
ANTM' s Net Margin % Range Over the Past 10 Years
Min: 2.91  Med: 4.2 Max: 7.3
Current: 3.19
2.91
7.3
ROE % 11.22
ANTM's ROE % is ranked lower than
74% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.42 vs. ANTM: 11.22 )
Ranked among companies with meaningful ROE % only.
ANTM' s ROE % Range Over the Past 10 Years
Min: 10.25  Med: 11.23 Max: 20.5
Current: 11.22
10.25
20.5
ROA % 4.25
ANTM's ROA % is ranked lower than
52% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.26 vs. ANTM: 4.25 )
Ranked among companies with meaningful ROA % only.
ANTM' s ROA % Range Over the Past 10 Years
Min: 3.9  Med: 4.87 Max: 9.44
Current: 4.25
3.9
9.44
3-Year Revenue Growth Rate 10.60
ANTM's 3-Year Revenue Growth Rate is ranked higher than
52% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. ANTM: 10.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
ANTM' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: 12.1 Max: 18.3
Current: 10.6
0
18.3
3-Year EBITDA Growth Rate 9.40
ANTM's 3-Year EBITDA Growth Rate is ranked lower than
63% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.80 vs. ANTM: 9.40 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
ANTM' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 11.95 Max: 27.2
Current: 9.4
0
27.2
3-Year EPS without NRI Growth Rate 2.00
ANTM's 3-Year EPS without NRI Growth Rate is ranked lower than
71% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.40 vs. ANTM: 2.00 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
ANTM' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 7.5 Max: 27
Current: 2
0
27
GuruFocus has detected 7 Warning Signs with Anthem Inc $ANTM.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ANTM's 30-Y Financials

Financials (Next Earnings Date: 2017-07-26)


Revenue & Net Income
Equity & Asset
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

ANTM Guru Trades in Q3 2016

Steven Cohen 61,000 sh (New)
Signature Select Canadian Fund 72,650 sh (New)
Ray Dalio 74,679 sh (+73.67%)
HOTCHKIS & WILEY 3,707,313 sh (+50.36%)
Larry Robbins 5,597,242 sh (+41.37%)
First Eagle Investment 2,823,567 sh (+21.13%)
T Rowe Price Equity Income Fund 2,100,000 sh (+18.68%)
Lee Ainslie 9,480 sh (+1.94%)
David Dreman 6,094 sh (unchged)
Tom Gayner 224,000 sh (unchged)
Yacktman Fund 850,000 sh (unchged)
Bernard Horn 36,600 sh (unchged)
Paul Tudor Jones Sold Out
Donald Yacktman 1,055,235 sh (-0.09%)
Jim Simons 1,176,800 sh (-1.69%)
Barrow, Hanley, Mewhinney & Strauss 8,414,907 sh (-1.87%)
Jeff Auxier 54,844 sh (-2.14%)
Dodge & Cox 3,111,405 sh (-2.93%)
Vanguard Health Care Fund 3,209,633 sh (-8.74%)
First Pacific Advisors 32,450 sh (-21.52%)
Jeremy Grantham 779,806 sh (-31.02%)
Joel Greenblatt 19,304 sh (-44.48%)
» More
Q4 2016

ANTM Guru Trades in Q4 2016

NWQ Managers 9,000 sh (New)
Daniel Loeb 1,000,000 sh (New)
Paul Tudor Jones 4,800 sh (New)
Joel Greenblatt 28,408 sh (+47.16%)
Jim Simons 1,686,773 sh (+43.34%)
First Pacific Advisors 37,700 sh (+16.18%)
Larry Robbins 5,874,049 sh (+4.95%)
T Rowe Price Equity Income Fund 2,140,000 sh (+1.90%)
First Eagle Investment 2,825,954 sh (+0.08%)
Tom Gayner 224,000 sh (unchged)
Yacktman Fund 850,000 sh (unchged)
Bernard Horn 36,600 sh (unchged)
Ray Dalio 74,604 sh (-0.10%)
Jeff Auxier 54,694 sh (-0.27%)
Donald Yacktman 1,038,140 sh (-1.62%)
HOTCHKIS & WILEY 3,635,567 sh (-1.94%)
Dodge & Cox 3,005,018 sh (-3.42%)
Barrow, Hanley, Mewhinney & Strauss 8,053,028 sh (-4.30%)
Lee Ainslie 8,530 sh (-10.02%)
Jeremy Grantham 701,535 sh (-10.04%)
Vanguard Health Care Fund 2,666,933 sh (-16.91%)
David Dreman 4,815 sh (-20.99%)
Steven Cohen 5,000 sh (-91.80%)
» More
Q1 2017

ANTM Guru Trades in Q1 2017

Joel Greenblatt 33,398 sh (+17.57%)
Daniel Loeb 1,150,000 sh (+15.00%)
First Eagle Investment 2,988,930 sh (+5.77%)
Vanguard Health Care Fund 2,666,933 sh (unchged)
David Dreman 4,815 sh (unchged)
Tom Gayner 224,000 sh (unchged)
Yacktman Fund 850,000 sh (unchged)
Bernard Horn 36,600 sh (unchged)
Steven Cohen Sold Out
Ray Dalio Sold Out
Donald Yacktman 1,034,437 sh (-0.36%)
T Rowe Price Equity Income Fund 2,120,000 sh (-0.93%)
HOTCHKIS & WILEY 3,549,970 sh (-2.35%)
Lee Ainslie 8,290 sh (-2.81%)
Jeff Auxier 52,194 sh (-4.57%)
Dodge & Cox 2,839,368 sh (-5.51%)
Barrow, Hanley, Mewhinney & Strauss 7,536,964 sh (-6.41%)
Signature Select Canadian Fund 66,300 sh (-8.74%)
Jeremy Grantham 632,547 sh (-9.83%)
NWQ Managers 8,000 sh (-11.11%)
Larry Robbins 4,711,645 sh (-19.79%)
Jim Simons 1,235,600 sh (-26.75%)
Paul Tudor Jones 2,600 sh (-45.83%)
First Pacific Advisors 14,600 sh (-61.27%)
» More
Q2 2017

ANTM Guru Trades in Q2 2017

Yacktman Fund 850,000 sh (unchged)
T Rowe Price Equity Income Fund 2,027,400 sh (-4.37%)
» More
» Details

Insider Trades

Latest Guru Trades with NYSE:ANTM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 524114    SIC: 6324
Compare:NYSE:AET, NYSE:CI, NAS:ESRX, NYSE:HUM, NYSE:CVS, NYSE:CNC, NYSE:WCG, NYSE:MOH, NAS:MGLN, NAS:HIIQ, OTCPK:OPRX, OTCPK:WCUI, NAS:CNXR, NYSE:UNH » details
Traded in other countries:A58.Germany, ANTM.Mexico,
Headquarter Location:USA
Anthem Inc is a health benefits company offering a network-based managed care plans to the large and small employer, individual, Medicaid and Medicare markets. Its business segments are Commercial and Specialty Business, Government Business and Other.

With approximately 40 million medical members, Anthem is one of the largest managed-care organizations in the United States. The firm provides health insurance services to its members through a plethora of products that encompass every major insurance market--individual, group, and government-sponsored. The firm operates under the highly recognizable Blue Cross/Blue Shield brand in 14 states and has a large nationwide operation.

Guru Investment Theses on Anthem Inc

Jeff Auxier Comments on Anthem - May 09, 2017

Anthem (NYSE:ANTM) is a leading managed care operator which operates under the Blue Cross/Blue Shield brand. Fourth quarter net income was up 103% year over year as medical enrollment increased 3.4%. They are expecting their operating cash flow to be greater than $3.5B in 2017.


From Jeff Auxier (Trades, Portfolio)'s Auxier Asset Management first quarter 2017 shareholder letter.

Check out Jeff Auxier latest stock trades

Bernard Horn Comments on Anthem - Apr 21, 2017

From the outset, investors and analysts raised concerns about the proposed merger between U.S. health insurers, Anthem, Inc. and Cigna. In early January 2017, a federal judge blocked the proposed merger, siding with the Department of Justice. Anthem (NYSE:ANTM) stock rose in the ensuing three months, up more than 15% at the end of March, as investors were relieved about the deal cancellation. In February, the Centers for Medicare & Medicaid Services proposed rules aimed at stabilizing the Affordable Care Act (ACA) individual and small group insurance markets. This bodes well for Anthem Inc., and other health insurers, as the rule may help stem the tide of financial losses currently associated with ACA participation.

From Bernard Horn (Trades, Portfolio)'s Polaris Global Fund first quarter 2017 shareholder letter.

Check out Bernard Horn latest stock trades

Bernard Horn Comments on Anthem Inc. - Mar 21, 2016

M&A activity was also heating up in the health insurer industry, with the CFO of Anthem Inc. (NYSE:ANTM) suggesting the company could make a “meaningful” acquisition. Thereafter, Anthem entered negotiations to buy Cigna. In addition to this strategy, Anthem also announced strong earnings, deploying capital in the form of share buybacks and dividends.

From Bernard Horn (Trades, Portfolio)'s Global Value Fund annual letter 2015.



Check out Bernard Horn latest stock trades

Top Ranked Articles about Anthem Inc

Jeff Auxier Comments on Anthem Guru stock highlight
Anthem (NYSE:ANTM) is a leading managed care operator which operates under the Blue Cross/Blue Shield brand. Fourth quarter net income was up 103% year over year as medical enrollment increased 3.4%. They are expecting their operating cash flow to be greater than $3.5B in 2017.
Read more...
Yacktman Buys Troubled Express Scripts, Sells S&P 500 Yacktman Funds' new holding just lost its biggest client, and the firm sold three stocks
Yacktman Asset Management, known for tight risk control, dodged the dot-com bubble of the early 2000s but underperformed in the past five years as its value style fell out of sync with market forces. Read more...
Bernard Horn Comments on Anthem Guru stock highlight
From the outset, investors and analysts raised concerns about the proposed merger between U.S. health insurers, Anthem, Inc. and Cigna. In early January 2017, a federal judge blocked the proposed merger, siding with the Department of Justice. Anthem (NYSE:ANTM) stock rose in the ensuing three months, up more than 15% at the end of March, as investors were relieved about the deal cancellation. In February, the Centers for Medicare & Medicaid Services proposed rules aimed at stabilizing the Affordable Care Act (ACA) individual and small group insurance markets. This bodes well for Anthem Inc., and other health insurers, as the rule may help stem the tide of financial losses currently associated with ACA participation. Read more...
Analysts Release New Health Care Stock Ratings Jeffries downgrades Amgen to hold from buy
Analysts released new ratings for some health care stocks recently. Read more...
Investor Confidence in Cigna and Anthem Rises as Health Care Mergers Dealt Blows Both companies gained as dates for decisions pushed back to Trump administration
As a judge struck down a mega merger between health care giants Aetna (NYSE:AET) and Humana (NYSE:HUM) on Tuesday, investor confidence seemed to grow for two other companies seeking to unite in a similar deal, Cigna (NYSE:CI) and Anthem (NYSE:ANTM). Read more...
9 Stocks Ray Dalio Continues to Buy Holdings the guru increased in the 2nd and 3rd quarters
Ray Dalio (Trades, Portfolio) founded his Connecticut-based hedge fund, Bridgewater Associates, in 1975. In both the second quarter and third quarter, the guru increased his position in the following stocks: Read more...
The Top 5 Buys of the Signature Select Canadian Fund Fund reports third quarter portfolio
CI Investment’s Signature Select Canadian Fund (Trades, Portfolio) focuses on long-term gains and through investing in common shares, convertible securities, preferred shares and dividends. It trades mostly companies based in Canada and is diversified across industry sectors. Read more...
Oaktree Reduces, Eliminates Multiple Positions in the 3rd Quarter Firm's largest sales of the quarter
Howard Marks (Trades, Portfolio) is the chairman of Oaktree Capital Management LP, which was founded in 1995. The firm made the following trades in the third quarter: Read more...
Vanguard Health Care Fund Sells Amgen, Baxter The guru's largest 3rd-quarter sales
Following its third-quarter report, Vanguard Health Care Fund (Trades, Portfolio) holds 73 stocks with a total value of $46.245 billion. The following are the sales with the largest impacts on its portfolio. Read more...
15 Best Undervalued Stocks of the Week Companies reviewed by ModernGraham
I evaluated 35 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. I also put each company through the ModernGraham valuation model, based on Benjamin Graham's value investing formulas, in order to determine an intrinsic value for each. Out of those 35 companies, only 15 were found to be undervalued or fairly valued and suitable for either Defensive or Enterprising Investors. Therefore, these 5 companies are the best undervalued stocks of the week. Read more...

Ratios

vs
industry
vs
history
PE Ratio 18.49
ANTM's PE Ratio is ranked higher than
68% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.18 vs. ANTM: 18.49 )
Ranked among companies with meaningful PE Ratio only.
ANTM' s PE Ratio Range Over the Past 10 Years
Min: 4.33  Med: 10.52 Max: 18.68
Current: 18.49
4.33
18.68
Forward PE Ratio 16.26
ANTM's Forward PE Ratio is ranked higher than
73% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.39 vs. ANTM: 16.26 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 18.49
ANTM's PE Ratio without NRI is ranked higher than
71% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.18 vs. ANTM: 18.49 )
Ranked among companies with meaningful PE Ratio without NRI only.
ANTM' s PE Ratio without NRI Range Over the Past 10 Years
Min: 4.33  Med: 10.36 Max: 18.68
Current: 18.49
4.33
18.68
Price-to-Owner-Earnings 13.50
ANTM's Price-to-Owner-Earnings is ranked lower than
53% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.73 vs. ANTM: 13.50 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
ANTM' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 4.16  Med: 12.13 Max: 35.03
Current: 13.5
4.16
35.03
PB Ratio 1.94
ANTM's PB Ratio is ranked higher than
87% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.78 vs. ANTM: 1.94 )
Ranked among companies with meaningful PB Ratio only.
ANTM' s PB Ratio Range Over the Past 10 Years
Min: 0.71  Med: 1.15 Max: 2.11
Current: 1.94
0.71
2.11
PS Ratio 0.59
ANTM's PS Ratio is ranked higher than
58% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.64 vs. ANTM: 0.59 )
Ranked among companies with meaningful PS Ratio only.
ANTM' s PS Ratio Range Over the Past 10 Years
Min: 0.26  Med: 0.44 Max: 0.93
Current: 0.59
0.26
0.93
Price-to-Free-Cash-Flow 13.05
ANTM's Price-to-Free-Cash-Flow is ranked lower than
53% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.35 vs. ANTM: 13.05 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
ANTM' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 5.81  Med: 11.34 Max: 50.53
Current: 13.05
5.81
50.53
Price-to-Operating-Cash-Flow 11.34
ANTM's Price-to-Operating-Cash-Flow is ranked lower than
55% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.27 vs. ANTM: 11.34 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
ANTM' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.17  Med: 9.87 Max: 26.92
Current: 11.34
5.17
26.92
EV-to-EBIT 7.43
ANTM's EV-to-EBIT is ranked higher than
85% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.25 vs. ANTM: 7.43 )
Ranked among companies with meaningful EV-to-EBIT only.
ANTM' s EV-to-EBIT Range Over the Past 10 Years
Min: 1.5  Med: 5.9 Max: 10.4
Current: 7.43
1.5
10.4
EV-to-EBITDA 6.39
ANTM's EV-to-EBITDA is ranked higher than
86% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.19 vs. ANTM: 6.39 )
Ranked among companies with meaningful EV-to-EBITDA only.
ANTM' s EV-to-EBITDA Range Over the Past 10 Years
Min: 1.4  Med: 5.2 Max: 9.8
Current: 6.39
1.4
9.8
PEG Ratio 1.59
ANTM's PEG Ratio is ranked higher than
64% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.82 vs. ANTM: 1.59 )
Ranked among companies with meaningful PEG Ratio only.
ANTM' s PEG Ratio Range Over the Past 10 Years
Min: 0.27  Med: 0.71 Max: 8.93
Current: 1.59
0.27
8.93
Shiller PE Ratio 21.98
ANTM's Shiller PE Ratio is ranked higher than
77% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 27.81 vs. ANTM: 21.98 )
Ranked among companies with meaningful Shiller PE Ratio only.
ANTM' s Shiller PE Ratio Range Over the Past 10 Years
Min: 9.07  Med: 14.45 Max: 22.32
Current: 21.98
9.07
22.32

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.36
ANTM's Dividend Yield % is ranked higher than
94% of the 31 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.38 vs. ANTM: 1.36 )
Ranked among companies with meaningful Dividend Yield % only.
ANTM' s Dividend Yield % Range Over the Past 10 Years
Min: 0.31  Med: 1.57 Max: 2.16
Current: 1.36
0.31
2.16
Dividend Payout Ratio 0.25
ANTM's Dividend Payout Ratio is ranked higher than
58% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.25 vs. ANTM: 0.25 )
Ranked among companies with meaningful Dividend Payout Ratio only.
ANTM' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.14  Med: 0.18 Max: 0.28
Current: 0.25
0.14
0.28
3-Year Dividend Growth Rate 20.10
ANTM's 3-Year Dividend Growth Rate is ranked higher than
62% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.70 vs. ANTM: 20.10 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
ANTM' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 29.5
Current: 20.1
0
29.5
Forward Dividend Yield % 1.36
ANTM's Forward Dividend Yield % is ranked higher than
89% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.65 vs. ANTM: 1.36 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 3.87
ANTM's 5-Year Yield-on-Cost % is ranked higher than
95% of the 41 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.04 vs. ANTM: 3.87 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
ANTM' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.88  Med: 4.44 Max: 6.11
Current: 3.87
0.88
6.11
3-Year Average Share Buyback Ratio 3.50
ANTM's 3-Year Average Share Buyback Ratio is ranked higher than
78% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.00 vs. ANTM: 3.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ANTM' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -43.1  Med: 8.55 Max: 0
Current: 3.5
-43.1
0

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 83.11
ANTM's Price-to-Tangible-Book is ranked lower than
100% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.27 vs. ANTM: 83.11 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
ANTM' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.72  Med: 12.93 Max: 180.12
Current: 83.11
1.72
180.12
Price-to-Intrinsic-Value-Projected-FCF 0.80
ANTM's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
76% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.04 vs. ANTM: 0.80 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
ANTM' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.32  Med: 0.48 Max: 1.47
Current: 0.8
0.32
1.47
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.55
ANTM's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
60% of the 10 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.60 vs. ANTM: 1.55 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.34
ANTM's Price-to-Median-PS-Value is ranked lower than
59% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.23 vs. ANTM: 1.34 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
ANTM' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.72  Med: 1.1 Max: 2.54
Current: 1.34
0.72
2.54
Price-to-Peter-Lynch-Fair-Value 1.64
ANTM's Price-to-Peter-Lynch-Fair-Value is ranked higher than
50% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.63 vs. ANTM: 1.64 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
ANTM' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.29  Med: 0.69 Max: 3.13
Current: 1.64
0.29
3.13
Price-to-Graham-Number 8.27
ANTM's Price-to-Graham-Number is ranked lower than
100% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.77 vs. ANTM: 8.27 )
Ranked among companies with meaningful Price-to-Graham-Number only.
ANTM' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.02  Med: 2.4 Max: 11.61
Current: 8.27
1.02
11.61
Earnings Yield (Greenblatt) % 13.46
ANTM's Earnings Yield (Greenblatt) % is ranked higher than
88% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.85 vs. ANTM: 13.46 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ANTM' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 9.6  Med: 16.9 Max: 67.2
Current: 13.46
9.6
67.2
Forward Rate of Return (Yacktman) % 16.86
ANTM's Forward Rate of Return (Yacktman) % is ranked higher than
53% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.88 vs. ANTM: 16.86 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
ANTM' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 6.2  Med: 22.3 Max: 43.6
Current: 16.86
6.2
43.6

More Statistics

Revenue (TTM) (Mil) $87,100.40
EPS (TTM) $ 10.31
Beta0.73
Short Percentage of Float2.15%
52-Week Range $114.85 - 194.94
Shares Outstanding (Mil)264.99

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 88,365 93,923 100,780
EPS ($) 11.56 13.11 14.42
EPS without NRI ($) 11.56 13.11 14.42
EPS Growth Rate
(Future 3Y To 5Y Estimate)
13.38%
Dividends per Share ($) 2.64 2.70 2.78
» More Articles for ANTM

Headlines

Articles On GuruFocus.com
Cigna Improves Earnings Despite Policy Uncertainty Over Obamacare Jun 06 2017 
Jeff Auxier Comments on Anthem May 09 2017 
7 Rising Stocks That Beat the Market May 09 2017 
Yacktman Buys Troubled Express Scripts, Sells S&P 500 May 03 2017 
Bernard Horn Comments on Anthem Apr 21 2017 
Bernard Horn's 1st Quarter 2017 Polaris Global Fund Commentary Apr 21 2017 
High Predictability Guru Stocks Apr 10 2017 
Analysts Release New Health Care Stock Ratings Apr 07 2017 
A Market of Extremes Mar 14 2017 
Since the Merger With Cigna Seems Doomed, What Are We to Think of Anthem? Feb 22 2017 

More From Other Websites
Health Carrier Stocks Need to Hold These Levels Jul 19 2017
Zacks.com featured highlights: Louisiana-Pacific, Huntington Ingalls Industries, Anthem, Eversource... Jul 19 2017
Republican push to end Obamacare collapses in U.S. Senate Jul 18 2017
UnitedHealth beats profit estimates after Obamacare exit Jul 18 2017
Employers Challenged by Expensive and Time-Consuming Specialty Drugs, According to Benefits... Jul 17 2017
[$$] Barron's First-Half Grades for Stock-Picking Are In Jul 14 2017
[$$] States to Health Insurers: Please Come Back Jul 14 2017
Why Anthem (ANTM) is Such a Great Value Stock Pick Right Now Jul 14 2017
[$$] Anthem Files Civil Suit Against Insys Therapeutics Jul 13 2017
Anthem files lawsuit against Insys Therapeutics Jul 13 2017
[$$] Anthem's New Chapter After Cigna Jul 13 2017
New Strong Buy Stocks for July 13th Jul 13 2017
Watching for Buying Signals Near Trendline Support Jul 12 2017
Zacks.com featured highlights: Anthem (HealthCare), ManPowerGroup (Professional & Business... Jul 12 2017
Community Health to Divest Texas Hospital to HCA Healthcare Jul 12 2017
Sessions to Unveil Health-Care Fraud Crackdown This Week, Sources Say Jul 11 2017
U.S. Senate may vote on revised healthcare bill next week Jul 11 2017
Winning Stock Picks from the Top 4 Industries with the Biggest Job Growth Jul 11 2017
Anthem to Hold Conference Call and Webcast to Discuss Second Quarter Results on July 26, 2017 Jul 06 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}